宏基因组联合UPLC-Q-TOF-MS/MS探讨地塞米松对大鼠肺炎的作用机制

李四菊; 张倩; 冷云; 潘碧妍; 谢智勇; 陈红英

doi:10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).2023.0207

您当前的位置：

首页 >

文章列表页 >

宏基因组联合UPLC-Q-TOF-MS/MS探讨地塞米松对大鼠肺炎的作用机制

基础研究 | 更新时间：2024-02-19

- 宏基因组联合UPLC-Q-TOF-MS/MS探讨地塞米松对大鼠肺炎的作用机制
- Integrated Metagenomics and UPLC-Q-TOF-MS/MS to Explore the Mechanism of Dexamethasone on Pneumonia in Rats
- 中山大学学报（医学科学版） 2023年44卷第2期页码：232-243
- 作者机构：
  
  1.中山大学药学院（深圳），广东深圳 518107
  2.广州白云山明兴制药有限公司，广东广州 510000
  3.中南大学湘雅医院临床药理研究所，湖南长沙 410008
- 作者简介：
  
  李四菊，硕士生，研究方向：肠道微生态学，非靶标代谢组学，E-mail： lisj39@mail2.sysu.edu.cn
- 基金信息：
  
  国家自然科学基金(U1903211;82174104)
- DOI：10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).2023.0207
  中图分类号： R563.1;R-332
- 纸质出版日期：2023-03-20，
  
  收稿日期：2022-11-01，
扫描看全文
李四菊,张倩,冷云等.宏基因组联合UPLC-Q-TOF-MS/MS探讨地塞米松对大鼠肺炎的作用机制[J].中山大学学报（医学科学版）,2023,44(02):232-243.

LI Si-ju,ZHANG Qian,LENG Yun,et al.Integrated Metagenomics and UPLC-Q-TOF-MS/MS to Explore the Mechanism of Dexamethasone on Pneumonia in Rats[J].Journal of Sun Yat-sen University(Medical Sciences),2023,44(02):232-243.
李四菊,张倩,冷云等.宏基因组联合UPLC-Q-TOF-MS/MS探讨地塞米松对大鼠肺炎的作用机制[J].中山大学学报（医学科学版）,2023,44(02):232-243. DOI： 10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).2023.0207.

LI Si-ju,ZHANG Qian,LENG Yun,et al.Integrated Metagenomics and UPLC-Q-TOF-MS/MS to Explore the Mechanism of Dexamethasone on Pneumonia in Rats[J].Journal of Sun Yat-sen University(Medical Sciences),2023,44(02):232-243. DOI： 10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).2023.0207.

摘要

目的

基于多组学技术，探讨地塞米松（Dex）能否通过调节肠道菌群及代谢物治疗肺炎。

方法

将18只Sprague-Dawley大鼠随机均分为对照（Control）组、模型（Model）组和地塞米松（Dex）组，每组6只，除Control组外，余下两组持续使用4 mg/kg的脂多糖（LPS）腹腔注射7 d建立大鼠肺炎模型。然后Dex组给予2 mg/kg的Dex灌胃治疗12 d，余下两组均连续灌胃等量的无菌PBS缓冲液12 d。第19 d时收集大鼠的肺组织、血浆、粪便和肠道内容物。苏木精-伊红（H&E）染色和Bio-plex悬浮芯片系统评价Dex的药效。宏基因组测序和超高效液相色谱串联四极杆飞行时间高分辨率质谱（UPLC-Q-TOF-MS/MS）技术分别测定大鼠的肠道菌群和代谢物。

结果

E染色结果显示Model组大鼠肺组织炎症细胞浸润增加，肺泡间隔增大，肺泡出血，给予Dex治疗后肺组织病变得以缓解。与Control组相比，Model组中的3种炎症因子TNF-α（

0.000 1）、IL-1α（

= 0.009 6）和IL-6（

0.000 1）含量升高，Dex治疗后能降低3种炎症因子水平。综上所述，Dex给药能有效的缓解肺炎大鼠的症状。宏基因组分析表明3组大鼠的肠道菌群结构改变，与Model组相比，Dex组厚壁菌门的相对丰度升高，厚壁菌门/拟杆菌门比例增加，双歧杆菌科、毛螺菌科和乳酸杆菌科积累。多变量统计分析显示Model组和Dex组极大的分离，揭示代谢轮廓改变。此外，Model组与Dex组筛选出69个（

0.05）差异代谢物，包括Model组中上调的38个代谢物和Dex组上调的31个代谢物，这些差异代谢物主要参与了亚油酸代谢、色氨酸代谢和初级胆汁酸生物合成这3条代谢通路。

结论

我们证明了Dex对肺炎大鼠的有益作用，与此同时，宏基因组学联用UPLC-Q-TOF-MS/MS非靶标代谢组学，揭示了Dex通过调节肠道菌群和宿主代谢物治疗LPS诱导的大鼠肺炎，本研究可能为Dex治疗大鼠肺炎的作用机制提供新见解。

Abstract

Objective

Using multi-omics technology， we conducted the present study to determine whether dexamethasone has therapeutic effect on pneumonia rats through the regulation of intestinal flora and metabolites.

Methods

Totally 18 Sprague-Dawley rats were randomly divided into 3 groups （

= 6 each）： Control group， Model group and Dexamethasone （Dex） group. Lipopolysaccharide （LPS） was continuously injected intraperitoneally into rats at a dose of 4 mg/kg for 7 days to induce pneumonia except the Control group. Then the Dex group was given Dex at a dose of 2 mg/kg via oral gavage for 12 days， and both the other two groups received continuously equal volume of sterile PBS buffer for 12 days. On the 19th day， lung， plasma， feces and intestinal contents of rat were collected. Hematoxylin-eosin （H

E） staining and Bio-plex suspension chip system were applied to evaluate the effect of Dex on pneumonia. Furthermore， metagenomic sequencing and UPLC-Q-TOF-MS/MS technology were employed to determine the intestinal flora and metabolites of rats， respectively.

Results

E staining results showed that the lung tissue of the Model group was infiltrated with inflammatory cells， the alveolar septum was increased， alveolar hemorrhage， and histological lesions were less severe in Dex group than in the model group. The levels of 3 inflammatory cytokines including TNF-α （

0.000 1）， IL-1α （

= 0.009 6） and IL-6 （

0.000 1） in the Model group were increased compared with the Control group， while Dex treatment reduced the levels of the three inflammatory factors. Taken together， Dex treatment effectively reversed the features of pneumonia in rats. Metagenomic analysis revealed that the intestinal flora structure of the three groups of rats was changed. In contrast with the Model group， an increasing level of the Firmicutes and an elevated proportion of Firmicutes/Bacteroidetes were observed after Dex treatment. Dex-treated rats possessed notably enrichment of Bifidobacterium， Lachnospiraceae and Lactobacillus. Multivariate statistical analysis showed a great separation between Model group and Dex group， indicating metabolic profile changes. In addition， 69 metabolites （

0.05） were screened， including 38 up-regulated in the Model group and 31 elevated in the Dex group， all of which were mainly involved in 3 metabolic pathways： linoleic acid metabolism， tryptophan metabolism and primary bile acid biosynthesis.

Conclusions

In summary， we demonstrate the beneficial effects of Dex on the symptoms of pneumonia. Meanwhile， integrated microbiome-metabolome analysis reveals that Dex improves LPS-induced pneumonia in rats through regulating intestinal flora and host metabolites. This study may provide new insights into the mechanism of Dex treatment of pneumonia in rats.

关键词

肺炎地塞米松肠道菌群代谢组学超高效液相色谱串联四极杆飞行时间高分辨率质谱

Keywords

pneumoniadexamethasoneintestinal florametabolomicsUPLC-Q-TOF-MS/MS

references

Zhang Y， Li Y， Sun N， et al. NETosis is critical in patients with severe community-acquired pneumonia［J］. Front Immunol， 2022， 13： 1051140.

颜妍，肖伟利，钟明月，等. 蒙古黄芪多糖通过调控Nrf-2信号通路缓解地塞米松诱导的糖脂代谢紊乱［J］.中国免疫学杂志， 2020， 36（3）： 289-293.

Yan Y， Xiao WL， Zhong MY， et al. Mitigating effect of Mongolia astragalus polysaccharide against dexamethasoneinduced glucose and lipid metabolism disorder through regulation on Nrf-2 signaling pathway［J］. Chin J Immunol， 2020， 36（3）： 289-293.

Wittermans E， Vestjens SMT， Spoorenberg SMC， et al. Adjunctive treatment with oral dexamethasone in non-ICU patients hospitalised with community-acquired pneumonia： a randomised clinical trial［J］. Eur Respir J， 2021， 58（2）： 2002535.

Rastogi S， Mohanty S， Sharma S， et al. Possible role of gut microbes and host's immune response in gut-lung homeostasis［J］. Front Immunol， 2022， 13： 954339.

Dickson RP， Singer BH， Newstead MW， et al. Enrichment of the lung microbiome with gut bacteria in sepsis and the acute respiratory distress syndrome［J］. Nat Microbiol， 2016， 1（10）： 16113.

Manzanares W， Lemieux M， Langlois PL， et al. Probiotic and synbiotic therapy in critical illness： a systematic review and meta-analysis［J］. Crit Care， 2016， 19： 262.

Li J， Luu LDW， Wang X， et al. Metabolomic analysis reveals potential biomarkers and the underlying pathogenesis involved in Mycoplasma pneumoniae pneumonia［J］. Emerg Microbes Infect， 2022， 11（1）： 593-605.

Wang Y， Li N， Li Q， et al. Xuanbai Chengqi Decoction ameliorates pulmonary inflammation via reshaping gut microbiota and rectifying Th17/Treg imbalance in a murine model of chronic obstructive pulmonary disease［J］. Int J Chron Obstruct Pulmon Dis， 2021， 16： 3317-3335.

Wang M， Xie Z， Li L， et al. Supplementation with compound polysaccharides contributes to the development and metabolic activity of young rat intestinal microbiota［J］. Food Funct， 2019， 10（5）： 2658-2675.

高磊，张英剑，刘晓敏，等. 不同发病状态的溃疡性结肠炎患者血清炎症因子和免疫球蛋白变化及与肠道菌群变化的相关性［J］. 广东医学， 2021， 42（11）： 1342-1346.

Gao L， Zhang YJ， Liu XM， et al. Changes in serum inflammatory factors and immunoglobulins in patients with ulcerative colitis of different morbidity states and correlation with changes in intestinal flora［J］. Guangdong Med J， 2021， 42（11）： 1342-1346.

Wang Y， Wang B， Wu J， et al. Modulation of gut microbiota in pathological states［J］. Engineering， 2017， 3（1）： 83-89.

龚文斌，陈军，顾国胜，等. 肠内营养治疗克罗恩病的机制探讨［J］. 中华炎性肠病杂志， 2021， 5（4）： 356-359.

Gong WB， Chen J， Gu GS， et al. Exploring the mechanism of enteral nutrition for the treatment of Crohn's disease［J］. Chin J Inflamm Bowel Dis， 2021， 5（4）： 356-359.

Ley RE， Turnbaugh PJ， Klein S， et al. Human gut microbes associated with obesity［J］. Nature， 2006， 444（21）： 1022-1023.

Ni Y， Yang X， Zheng L， et al. Lactobacillus and bifidobacterium improves physiological function and cognitive ability in aged mice by the regulation of gut microbiota［J］. Mol Nutr Food Res， 2019， 63（22）： e1900603.

Layden BT， Angueira AR， Brodsky M， et al. Short chain fatty acids and their receptors： new metabolic targets［J］. Transl Res， 2013， 161（3）： 131-140.

Yao Y， Cai X， Fei W， et al. The role of short-chain fatty acids in immunity， inflammation and metabolism［J］. Crit Rev Food Sci Nutr， 2022， 62（1）： 1-12.

Arrieta MC， Stiemsma LT， Dimitriu PA， et al. Early infancy microbial and metabolic alterations affect risk of childhood asthma［J］. Sci Transl Med， 2015， 7（307）： 307ra152.

Chen Y， Wang J， Yu L， et al. Microbiota and metabolome responses in the cecum and serum of broiler chickens fed with plant essential oils or virginiamycin［J］. Sci Rep， 2020， 10（1）： 5382.

Liu Y， Wang X， Hu CA. Therapeutic potential of amino acids in inflammatory bowel disease［J］. Nutrients， 2017， 9（9）： 920.

Platten M， EaANollen， Rohrig UF， et al. Tryptophan metabolism as a common therapeutic target in cancer， neurodegeneration and beyond［J］. Nat Rev Drug Discov， 2019， 18（5）： 379-401.

Laiakis EC， Morris GA， Fornace AJ， et al. Metabolomic analysis in severe childhood pneumonia in the Gambia， West Africa： findings from a pilot study［J］. PLoS One， 2010， 5（9）： e12655.

Agus A， Planchais J， Sokol H. Gut microbiota regulation of tryptophan metabolism in health and disease［J］. Cell Host Microbe， 2018， 23（6）： 716-724.

Castane H， Iftimie S， Baiges-Gaya G， et al. Machine learning and semi-targeted lipidomics identify distinct serum lipid signatures in hospitalized COVID-19-positive and COVID-19-negative patients［J］. Metabolism， 2022， 131： 155197.

Niu F， Xu X， Zhang R， et al. Ursodeoxycholic acid stimulates alveolar fluid clearance in LPS-induced pulmonary edema via ALX/cAMP/PI3K pathway［J］. J Cell Physiol， 2019， 234（11）： 20057-20065.

Hou Y， Nie Y， Cheng B， et al. Qingfei Xiaoyan Wan， a traditional Chinese medicine formula， ameliorates pseudomonas aeruginosa-induced acute lung inflammation by regulation of PI3K/AKT and Ras/MAPK pathways［J］. Acta Pharm Sin B， 2016， 6（3）： 212-221.

Islam KB， Fukiya S， Hagio M， et al. Bile acid is a host factor that regulates the composition of the cecal microbiota in rats［J］. Gastroenterology， 2011， 141（5）： 1773-1781.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

类鼻疽肺炎的临床特征与CT影像学表现

免疫抑制宿主肺炎与淋巴细胞的相关性及激素对重症患者结局的影响

基于血清代谢组学研究黄芪甲苷抑制高脂喂养的Apc^Min/+小鼠结肠腺瘤性息肉形成

基于16S rDNA基因测序探讨咳嗽变异性哮喘与肠道菌群的关系

NMR联用HILIC-UPLC-MS/MS测定TNBS诱导的结肠炎大鼠尿液和血浆代谢物变化